Published in J Gen Virol on December 01, 1981
Latency versus persistence or intermittent recurrences: evidence for a latent state of murine cytomegalovirus in the lungs. J Virol (1997) 1.82
Identification of proteins associated with murine cytomegalovirus virions. J Virol (2004) 1.72
Frequent coinfection of cells explains functional in vivo complementation between cytomegalovirus variants in the multiply infected host. J Virol (2005) 1.46
Replication of murine cytomegalovirus in differentiated macrophages as a determinant of viral pathogenesis. J Virol (1999) 1.42
Virulence characteristics of murine cytomegalovirus in cell and organ cultures. Infect Immun (1983) 1.09
Rash produced by mouse cytomegalovirus. Infect Immun (1983) 0.91
Attenuated murine cytomegalovirus binds to N-acetylglucosamine, and shift to virulence may involve recognition of sialic acids. J Virol (1990) 0.87
Elucidation of the block to herpes simplex virus egress in the absence of tegument protein UL16 reveals a novel interaction with VP22. J Virol (2013) 0.85
Pathogenesis of viral infections of the nervous system. N Engl J Med (1968) 2.48
Immunofluorescence study of the carrier state and mechanism of vertical transmission in lymphocytic choriomeningitis virus infection in mice. J Pathol Bacteriol (1966) 2.15
Antiviral action of immune lymphocytes in mice infected with lymphocytic choriomeningitis virus. Infect Immun (1972) 1.93
Effect of murine strain and viral strain on the pathogenesis of lymphocytic choriomeningitis infection and a study of footpad responses. J Infect Dis (1971) 1.87
Arenoviruses: proposed name for a newly defined virus group. J Virol (1970) 1.81
Cytopathic effect of Semliki Forest virus in the mosquito Aedes aegypti. Am J Trop Med Hyg (1966) 1.72
The role of macrophages in mice infected with murine cytomegalovirus. J Gen Virol (1978) 1.71
Pathogenesis of viral infections of the fetus. Prog Med Virol (1968) 1.64
Parainfluenza virus Sendai infection in macrophages, ependyma, choroid plexus, vascular endothelium and respiratory tract of mice. Am J Pathol (1973) 1.63
The immunodepressive action of lymphocytic choriomeningitis virus in mice. J Immunol (1968) 1.59
Interaction of influenza virus with mouse macrophages. Infect Immun (1981) 1.56
Antiviral activity of the dihydropyrone PNU-140690, a new nonpeptidic human immunodeficiency virus protease inhibitor. Antimicrob Agents Chemother (1997) 1.53
Plaque assay for lymphocytic choriomeningitis virus based on hemadsorption interference. J Virol (1967) 1.47
Pathogenesis of lesions in lymphoid tissue of mice infected with lymphocytic choriomeningitis (LCM) virus. Br J Exp Pathol (1969) 1.47
Fate of intravenously administered interferon and the distribution of interferon during virus infections in mice. Br J Exp Pathol (1966) 1.47
Identification of Arcobacter cryaerophilus isolated from a traffic accident victim with bacteremia by 16S ribosomal RNA gene sequencing. Diagn Microbiol Infect Dis (2001) 1.47
Macrophage activation in mice infected with ectromelia or lymphocytic choriomeningitis viruses. Aust J Exp Biol Med Sci (1973) 1.42
Transplacental transmission of polyoma virus in mice. Infect Immun (1977) 1.41
Reactivation of polyoma virus in kidneys of persistently infected mice during pregnancy. Infect Immun (1979) 1.36
Tipranavir (PNU-140690): a potent, orally bioavailable nonpeptidic HIV protease inhibitor of the 5,6-dihydro-4-hydroxy-2-pyrone sulfonamide class. J Med Chem (1998) 1.29
Splenic necrosis in mice infected with cytomegalovirus. J Infect Dis (1978) 1.25
Structure-based design of HIV protease inhibitors: sulfonamide-containing 5,6-dihydro-4-hydroxy-2-pyrones as non-peptidic inhibitors. J Med Chem (1996) 1.24
Mouse Ia antigens are receptors for lactate dehydrogenase virus. Nature (1984) 1.24
Vertical transmission of viruses. Microbiol Rev (1981) 1.23
Pathogenesis of rashes in virus diseases. Bacteriol Rev (1966) 1.21
Isolation of rubella virus from synovial fluid in five cases of seronegative arthritis. Lancet (1981) 1.18
Immunofluorescence study of the mechanism of resistance to superinfection in mice carrying the lymphocytic choriomeningitis virus. J Pathol Bacteriol (1966) 1.15
Viral infection in patients with multiple sclerosis and HLA-DR matched controls. Brain (1986) 1.15
Prophylactic administration of interleukin-2 protects mice from lethal challenge with gram-negative bacteria. Infect Immun (1987) 1.13
Influenza virus replication in human alveolar macrophages. J Med Virol (1982) 1.12
Structure-based design of HIV protease inhibitors: 4-hydroxycoumarins and 4-hydroxy-2-pyrones as non-peptidic inhibitors. J Med Chem (1994) 1.09
Infection of salivary glands, kidneys, adrenals, ovaries and epithelia by murine cytomegalovirus. J Med Microbiol (1979) 1.09
Effect on the fetus of maternal infection with lymphocytic choriomeningitis (LCM) virus. J Infect Dis (1969) 1.08
Structure-based design of nonpeptidic HIV protease inhibitors: the sulfonamide-substituted cyclooctylpyramones. J Med Chem (1997) 1.06
Observations on mice infected congenitally or neonatally with lymphocytic choriomeningitis (LCM) virus. Arch Gesamte Virusforsch (1970) 1.06
Factors in the mechanism of persistence of viral infections. Prog Med Virol (1974) 1.04
Chronic arthritis associated with the presence of intrasynovial rubella virus. Ann Rheum Dis (1983) 1.04
Interferon as a defence mechanism in mouse cytomegalovirus infection. J Gen Virol (1983) 1.01
Subclass distribution of IgG and IgA responses to rubella virus in man. J Med Microbiol (1986) 0.99
Pathogenesis of Ross River virus infection in mice. II. Muscle, heart, and brown fat lesions. J Infect Dis (1973) 0.98
Pattern of infection and selective loss of Ia positive cells in suckling and adult mice inoculated with lactic dehydrogenase virus. Arch Virol (1985) 0.96
Role of macrophage activation and interferon in the resistance of alveolar macrophages from infected mice to influenza virus. Infect Immun (1982) 0.95
Effect of oestrogen and 1,25-dihydroxycholecalciferol on 25-hydroxycholecalciferol metabolism in primary chick kidney-cell cultures. Biochem J (1978) 0.95
The functional similarity and structural diversity of human and cartilaginous fish hemoglobins. J Mol Biol (2001) 0.94
Infection of mice with lactic dehydrogenase virus prevents development of experimental allergic encephalomyelitis. J Neuroimmunol (1986) 0.94
Pathogenesis of Ross River virus infection in mice. I. Ependymal infection, cortical thinning, and hydrocephalus. J Infect Dis (1973) 0.93
The response of mice to the intravenous injection of cowpox virus. Br J Exp Pathol (1968) 0.93
Differential susceptibility of cultured neural cells to the human coronavirus OC43. J Virol (1985) 0.93
Interactions of viruses with the immune system. Clin Exp Immunol (1986) 0.91
Rash produced by mouse cytomegalovirus. Infect Immun (1983) 0.91
Selective vulnerability of neural cells and age-related susceptibility to OC43 virus in mice. Arch Virol (1983) 0.90
Enhancing antibodies, macrophages and virulence in mouse cytomegalovirus infection. J Gen Virol (1985) 0.90
Interferon production by mouse peritoneal cells. J Reticuloendothel Soc (1970) 0.89
The meaning of persistent infections in nature. Bull World Health Organ (1975) 0.88
Neutralization of different strains of murine cytomegalovirus (MCMV)-effect of in vitro passage. Arch Virol (1981) 0.88
Use of recombinant mitogillin for serodiagnosis of Aspergillus fumigatus-associated diseases. J Clin Microbiol (2001) 0.86
In vitro inhibition of human immunodeficiency virus type 1 by a combination of delavirdine (U-90152) with protease inhibitor U-75875 or interferon-alpha. J Infect Dis (1995) 0.86
Structure-based design of novel HIV protease inhibitors: sulfonamide-containing 4-hydroxycoumarins and 4-hydroxy-2-pyrones as potent non-peptidic inhibitors. J Med Chem (1996) 0.86
Bovine ephemeral fever virus in cell culture and mice. Arch Gesamte Virusforsch (1972) 0.85
The pathogenesis of nephritis in chickens induced by infectious bronchitis virus. J Comp Pathol (1982) 0.83
Live lactate dehydrogenase-elevating virus (LDV) induces suppressor T cells that inhibit the development of delayed hypersensitivity to LDV. J Gen Virol (1986) 0.83
Murine cytomegalovirus: reactivation in pregnancy. J Gen Virol (1980) 0.83
Association of virulence of murine cytomegalovirus with macrophage susceptibility and with virion-bound non-neutralizing antibody. J Gen Virol (1985) 0.82
Penile strangulation: report of two unusual cases. Singapore Med J (2009) 0.82
Virus receptors and cell tropisms. J Infect (1986) 0.82
Structure-based design of HIV protease inhibitors: 5,6-dihydro-4-hydroxy-2-pyrones as effective, nonpeptidic inhibitors. J Med Chem (1996) 0.81
Ia antigens and Fc receptors of mouse peritoneal macrophages as determinants of susceptibility to lactic dehydrogenase virus. J Gen Virol (1985) 0.81
Structure-based design of novel HIV protease inhibitors: carboxamide-containing 4-hydroxycoumarins and 4-hydroxy-2-pyrones as potent nonpeptidic inhibitors. J Med Chem (1995) 0.81
Expression of connective tissue growth factor (CTGF/CCN2) in head and neck squamous cell carcinoma. J Clin Pathol (2008) 0.81
Delayed hypersensitivity to murine cytomegalovirus and its depression during pregnancy. Infect Immun (1982) 0.80
Antigen-specific suppression of delayed type hypersensitivity to murine cytomegalovirus in MCMV-infected mice. J Gen Virol (1983) 0.80
Synthesis of antibodies, including antiviral antibodies, in the knee joints of patients with arthritis. Ann Rheum Dis (1985) 0.80
Evaluation of a vitamin-cloaking strategy for oligopeptide therapeutics: biotinylated HIV-1 protease inhibitors. J Med Chem (1994) 0.79
Uptake of heparin by peritoneal macrophages. Aust J Exp Biol Med Sci (1969) 0.79
A personal view of scrapie research. Lancet (1977) 0.78
Viral aetiology of diseases of obscure origin. Br Med Bull (1985) 0.78
Studies of depressed interleukin-2 production by spleen cells from mice following infection with cytomegalovirus. Arch Virol (1988) 0.78
General features of persistent virus infections. Postgrad Med J (1978) 0.77
Lymphokine-activated killer cells are rejected in vivo by activated natural killer cells. J Immunol (1991) 0.77
Generation of a protective human monoclonal for the treatment of gram-negative sepsis. Prog Clin Biol Res (1988) 0.76
A study of the production, source and action of interferon appearing in mice after the intravenous injection of influenza virus. Br J Exp Pathol (1967) 0.76
Alopecia in mice infected with murine cytomegalovirus (MCMV). Br J Exp Pathol (1985) 0.75
Thoracic lymph duct cannulation of mice infected with lymphocytic choriomeningitis (LCM) and ectromelia viruses. Arch Gesamte Virusforsch (1971) 0.75
Thoracic duct cannulation and hemal node formation in mice infected with cowpox virus. Br J Exp Pathol (1970) 0.75
A virus view of the human condition. Postgrad Med J (1995) 0.75
DMSO induces reactivation of cytomegalovirus in vitro from spleens of latently infected mice. Brief report. Arch Virol (1987) 0.75
Permanent cardiac pacing in Malaysia. An update. Ann Acad Med Singapore (1981) 0.75
Antiviral activity and dose optimum of recombinant macrophage colony-stimulating factor on herpes simplex genitalis in guinea pigs. J Immunol (1991) 0.75
Application of the recurrent multilayer perceptron in modeling complex process dynamics. IEEE Trans Neural Netw (1994) 0.75
The unique morphology of the lactic dehydrogenase virus. Microbios (1974) 0.75
Mineral matter and trace-element vaporization in a laboratory-pulverized coal combustion system. Environ Sci Technol (1982) 0.75
Structure-based design of nonpeptidic HIV protease inhibitors from a cyclooctylpyranone lead structure. J Med Chem (1995) 0.75
Effects of pregnant mouse serum and pregnancy hormones on the replication in vitro of murine cytomegalovirus. Arch Virol (1984) 0.75